Results 141 to 150 of about 11,928,997 (202)

Clinical Presentation of Chronic Abacterial Prostatitis Shows No Association with TAS2R38 Taster Status.

Urol Int
Rosellen J, Pilatz A, Schuppe HC, Schagdarsurengin U, Hofmann L, Deckmann K, Wagenlehner F.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hypertrophy of liver peroxisomes in type II and type IV hyperlipoproteinemia

Atherosclerosis, 1986
A morphometric study on liver biopsies from patients with primary hyperlipoproteinemia (IIa n = 4, IIb n = 7, IV n = 7) and in controls (n = 7) was performed by light and electron microscopy. We found hypertrophy of peroxisomes in all subjects with hyperlipoproteinemia.
P Drouin
exaly   +3 more sources

The spectrum of type III hyperlipoproteinemia

Journal of Clinical Lipidology, 2018
BACKGROUND: Type III hyperlipoproteinemia is a highly atherogenic dyslipoproteinemia characterized by hypercholesterolemia and hypertriglyceridemia due to markedly increased numbers of cholesterol-enriched chylomicron and very-low-density lipoprotein ...
Jacqueline de Graaf, Allan Sniderman
exaly   +2 more sources

Clofibrate in Type II Hyperlipoproteinemia

Acta Medica Scandinavica, 1976
ABSTRACT. As part of a double‐blind randomized study, the safety and the lipid‐ and uric acid‐lowering effect of clofibrate have been evaluated in 28 patients with type II hyperlipoproteinemia (HLP). A highly significant reduction of serum cholesterol occurred in type II a and of serum triglyceride and cholesterol in type IIb HLP throughout the 60 ...
J, Ditzel, H O, Bang
openaire   +2 more sources

Pseudohomozygous Type II Hyperlipoproteinemia

Dermatologica, 2009
Nodular xanthomas on both elbows and a streak-like xanthoma on the intergluteal area developed in a 4-year-old girl with type IIa hyperlipoproteinemia. She had no disease associated with secondary hypercholesterolemia and no family history of hypercholesterolemia. Her xanthomas regressed under fat restriction diet and cholestyramine therapy.
M, Fujita, S, Okamoto, K, Shirai, Y, Saito, S, Yoshida   +4 more
openaire   +2 more sources

Pseudohomozygous type II hyperlipoproteinemia

The Journal of Pediatrics, 1974
Familial hypercholesterolemia (a form of familial type II hyperlipoproteinemia) is transmitted as a dominant trait with homozygotes presenting in childhood with marked elevation of LDL and planar xanthormas. We studied two patients who presented as children with marked elevation of LDL and planar xanthomas but who, after family studies and clinical ...
J, Morganroth, R I, Levy, A E, McMahon, A M, Gotto   +3 more
openaire   +2 more sources

Sitosterol in juvenile type II hyperlipoproteinemia

Atherosclerosis, 1978
The effect of beta-sitosterol on plasma lipids and lipoproteins was evaluated in a randomized double-blind cross-over trial in 15 children and adolescents with familial hypercholesterolemia over a period of 6 months. Twelve patients completed the study, with good adherence to drug intake.
G, Schlierf, P, Oster, C C, Heuck, H, Raetzer, B, Schellenberg   +4 more
openaire   +2 more sources

Type II hyperlipoproteinaemia

Clinics in Endocrinology and Metabolism, 1973
Type II hyperlipoproteinemia is characterized by an abnormally high plasma β-lipoprotein concentration. Hence, an alternative name for the Type II lipoprotein pattern is hyper-β-lipoproteinemia. Although this pattern commonly occurs in the absence of any other lipoprotein abnormality, it may also occur in association with a raised concentration of ...
N B, Myant, J, Slack
openaire   +2 more sources

Special Diet for Familial Type II Hyperlipoproteinemia

Archives of Pediatrics & Adolescent Medicine, 1974
A suggested diet containing less than 200 mg cholesterol per day, with a polyunsaturate: saturate ratio of 0.9:1 was prepared for young children with familial hypercholesterolemia. A representative meal plan and calculations for a seven-day food intake allow for a practical, economical diet, low in cholesterol and saturated fat, but high in essential ...
R, Larsen, C J, Glueck, R, Tsang
openaire   +2 more sources

Treatment of type II hyperlipoproteinemia with d-thyroxine

Atherosclerosis, 1976
The effectiveness of a new, almost l-thyroxine free preparation of d-thyroxine (Dynothel) was tested in 15 patients with Type IIa and 4 patients with Type IIb hyperlipoproteinemia. Eleven patients with Type IIa and 3 with Type IIb were responsive to treatment and showed an average 26% decrease in plasma TC. This decrement in plasma TC was mirrored in a
A D, Rakow, H U, Klor, E, Kuter, H H, Ditschuneit, H, Ditschuneit   +4 more
openaire   +2 more sources